首页> 外文OA文献 >Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer

【2h】

Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer

机译：葫芦素B，一种吉西他滨的新型体内增效剂，对胰腺癌的低毒性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Iwanski, Gabriela B; Lee, Dhong H; En-Gal, Shlomit; Doan, Ngan B; Castor, Brandon; Vogt, Marco; Toh, Melvin; Bokemeyer, Carsten; Said, Jonathan W; Thoennissen, Nils H; Koeffler, H Phillip;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study [J] . Joal D. Beane, Kayla F. Griffin, Elliot B. Levy, Investigational New Drugs . 2015,第1期

机译：十二指肠缺血和上消化道出血是吉西他滨在胰头血管隔离后连续24h持续动脉内胰腺灌注的剂量限制性毒性：局部晚期胰腺癌（RECLAP）研究中区域化疗的早期结果
2. Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study [J] . Beane Joal D., Griffin Kayla F., Levy Elliot B., Investigational new drugs. . 2015,第1期

机译：十二指肠缺血和上消化道出血是吉西他滨在胰头血管隔离后24小时连续动脉内胰腺灌注的剂量限制性毒性：局部晚期胰腺癌（RECLAP）研究中区域化疗的早期结果
3. Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer [J] . Journal of geriatric oncology . 2020,第4期

机译：Gemcitabine Plus Nab-Paclitaxel随后用吉西他滨维持治疗，单独作为具有局部晚期或转移性胰腺癌的老年人的一线治疗方法
4. Changing the treatment paradigm: Ex vivo assessment of gemcitabine-eluting degradable polymeric fibres for the treatment of pancreatic cancer [C] . Simon Moulton, Amanda Zuzic, Samantha Wade, World biomaterials congress . 2016

机译：改变治疗范式：吉西他滨洗脱可降解聚合物纤维的离体评估，用于治疗胰腺癌
5. Formulation, Optimization and Efficacy of Gemcitabine Loaded Thermosensitive Liposomal Nanoparticles in the Treatment of Pancreatic Cancer [D] . Affram, Kevin Osei. 2018

机译：吉西他滨负载热敏脂质体纳米颗粒的制备，优化及疗效
6. Cucurbitacin B a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer [O] . Gabriela B Iwanski, Dhong H Lee, Shlomit En-Gal, 2010

机译：葫芦素B一种吉西他滨的新型体内增效剂对胰腺癌的低毒性
7. Induction gemcitabine and oxaliplatin therapy followed by a twice-weekly infusion of gemcitabine and concurrent external-beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer [O] . Francesco Leone, Marco Gatti, Paolo Massucco, 2012

机译：感应吉西他滨和奥沙利铂治疗，然后是吉西他滨两次输注吉西他滨和同时的外梁辐射，用于局部晚期胰腺癌的新辅助治疗

Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer

著录项

引文网络

相似文献

相关主题

期刊订阅